Advertisement
Table 5 The features of operation and postoperative complications in patients with APGC
| NSR (n = 572) | CR (n = 152) | SPR (n = 113) | P | |
|---|---|---|---|---|
| Operation time (min) | 192 ± 13 | 241 ± 21 | 221 ± 7 | < 0.001a |
| Intraoperativetransfusion | 154 (26.9%) | 68 (44.7%) | 36 (31.8%) | < 0.001b |
| Postoperativehospital stay (days) | 12.63 ± 1.45 | 15.25 ± 2.86 | 12.86 ± 1.68 | < 0.001a |
| Examined lymph nodes | 25.11 ± 13.71 | 28.38 ± 14.47 | 27.02 ± 11.32 | 0.018a |
| Non-lethal Complication | 48 (8.4%) | 34 (22.4%) | 14 (12.4%) | < 0.001b |
| Anastomotic leakage | 14 | 7 | 3 | |
| Pancreas-related complications | 6 | 10 | 0 | |
| Lung pleura- related complications | 7 | 6 | 2 | |
| Wound complication | 5 | 2 | 3 | |
| Postoperative ileus | 13 | 6 | 5 | |
| Liver dysfunction | 3 | 3 | 0 | |
| Mortality* | 3 | 9 | 1 | NS |
| Postoperative chemotherapy | 0.118 | |||
| Presence | 406(69.4%) | 96(16.4%) | 83(14.2%) | |
| Absence | 166(65.9%) | 56(22.2%) | 30(11.9%) |
